Global Insulin Glargine Market Size, Share, and COVID-19 Impact Analysis, By Type (Lantus, Basaglar, Toujeo, Soliqua, Rezvoglar, and Others), By Diabetes Type (Type 2 Diabetes, Type 1 Diabetes), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Retail Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Jun 2024
REPORT ID SI4502
PAGES 230
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By Diabetes Type
      3. Market Attractiveness Analysis By Distribution Channel
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increase prevalence of diabetes both type 1 and type 2
    3. Restraints
      1.  Cost concerns and availability of generic alternatives inhibit widespread adoption
    4. Opportunities
      1.  Advancement in insulin glargine formulations
    5. Challenges
      1. High cost of insulin glargine
  6. Global Insulin Glargine Market Analysis and Projection, By Type
    1. Segment Overview
    2. Lantus
    3. Basaglar
    4. Toujeo
    5. Soliqua
    6. Rezvoglar
    7. Others
  7. Global Insulin Glargine Market Analysis and Projection, By Diabetes Type
    1. Segment Overview
    2. Type 2 Diabetes
    3. Type 1 Diabetes
    4. Others
  8. Global Insulin Glargine Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacies
    3. Online Pharmacies
    4. Retail Pharmacies
  9. Global Insulin Glargine Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Insulin Glargine Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Insulin Glargine Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Biocon
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Gan & Lee 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Sanofi 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Kalbe Pharma 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Nova Nordisk AS 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Cipla Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Lupin Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Ypsomed AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Wockhardt 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Elli Lilly
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Biogenomics Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Polas Biopharm 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  2. Global Lantus, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  3. Global Basaglar, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  4. Global Toujeo, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  5. Global Soliqua, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  6. Global Rezvoglar, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  7. Global Others, Insulin Glargine Market, By Region, 2023-2033 ($ Billion)
  8. Global Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  9. Global Type 2 Diabetes, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  10. Global Type 1 Diabetes, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  11. Global Others, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  12. Global Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  13. Global Hospital Pharmacies, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  14. Global Online Pharmacies, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  15. Global Retail Pharmacies, Insulin Glargine Market, By Region, 2023-2033(USD Billion)
  16. North America Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  17. North America Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  18. North America Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  19. U.S.  Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  20. U.S.  Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  21. U.S.  Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  22. Canada Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  23. Canada Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  24. Canada Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)  
  25. Mexico Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  26. Mexico Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  27. Mexico Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  28. Europe Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  29. Europe Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  30. Europe Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  31. Germany Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  32. Germany Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  33. Germany Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  34. France Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  35. France Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  36. France Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  37. U.K.  Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  38. U.K.  Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  39. U.K.  Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  40. Italy Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  41. Italy Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  42. Italy Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  43. Spain Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  44. Spain Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  45. Spain Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  46. Asia Pacific Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  47. Asia Pacific Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  48. Asia Pacific Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  49. Japan Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  50. Japan Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  51. Japan Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  52. China Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  53. China Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  54. China Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  55. India Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  56. India Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  57. India Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  58. South America Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  59. South America Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  60. South America Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  61. Brazil Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  62. Brazil Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  63. Brazil Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  64. The Middle East and Africa Insulin Glargine Market, By Type, 2023-2033(USD   Billion)
  65. The Middle East and Africa Insulin Glargine Market, By Diabetes Type, 2023-2033(USD   Billion)
  66. The Middle East and Africa Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  67. UAE Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  68. UAE Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  69. UAE Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)
  70. South Africa Insulin Glargine Market, By Type, 2023-2033(USD Billion)
  71. South Africa Insulin Glargine Market, By Diabetes Type, 2023-2033(USD Billion)
  72. South Africa Insulin Glargine Market, By Distribution Channel, 2023-2033(USD Billion)

 

List of Figures 

  1. Global Insulin Glargine Market Segmentation
  2. Insulin Glargine Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Insulin Glargine Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Insulin Glargine Market
  20. Insulin Glargine Market Segmentation, By Type
  21. Insulin Glargine Market For Lantus, By Region, 2023-2033($ Billion)
  22.  Insulin Glargine Market For Basaglar, By Region, 2023-2033($ Billion)
  23. Insulin Glargine Market For Toujeo, By Region, 2023-2033($ Billion)
  24. Insulin Glargine Market For Soliqua, By Region, 2023-2033($ Billion)
  25. Insulin Glargine Market For Rezvoglar, By Region, 2023-2033($ Billion)
  26. Insulin Glargine Market For Others, By Region, 2023-2033 ($ Billion)
  27.  Insulin Glargine Market Segmentation, By Diabetes Type
  28.  Insulin Glargine Market For Type 2 Diabetes, By Region, 2023-2033($ Billion)
  29.  Insulin Glargine Market For Type 1 Diabetes, By Region, 2023-2033($ Billion)
  30. Insulin Glargine Market For Others, By Region, 2023-2033($ Billion)
  31. Insulin Glargine Market Segmentation, By Distribution Channel
  32. Insulin Glargine Market For Hospital Pharmacies, By Region, 2023-2033($ Billion)
  33. Insulin Glargine Market For Online Pharmacies, By Region, 2023-2033($ Billion)
  34. Insulin Glargine Market For Retail Pharmacies, By Region, 2023-2033($ Billion)
  35. Biocon: Net Sales, 2023-2033($ Billion)
  36. Biocon: Revenue Share, By Segment, 2023 (%)
  37. Biocon: Revenue Share, By Region, 2023 (%)
  38. Gan & Lee: Net Sales, 2023-2033($ Billion)
  39. Gan & Lee: Revenue Share, By Segment, 2023 (%)
  40. Gan & Lee: Revenue Share, By Region, 2023 (%)
  41. Sanofi: Net Sales, 2023-2033($ Billion)
  42. Sanofi: Revenue Share, By Segment, 2023 (%)
  43. Sanofi: Revenue Share, By Region, 2023 (%)
  44. Kalbe Pharma: Net Sales, 2023-2033($ Billion)
  45. Kalbe Pharma: Revenue Share, By Segment, 2023 (%)
  46. Kalbe Pharma: Revenue Share, By Region, 2023 (%)
  47. Nova Nordisk AS: Net Sales, 2023-2033($ Billion)
  48. Nova Nordisk AS: Revenue Share, By Segment, 2023 (%)
  49. Nova Nordisk AS: Revenue Share, By Region, 2023 (%)
  50. Cipla Inc.: Net Sales, 2023-2033($ Billion)
  51. Cipla Inc.: Revenue Share, By Segment, 2023 (%)
  52. Cipla Inc.: Revenue Share, By Region, 2023 (%)
  53. Lupin Ltd: Net Sales, 2023-2033($ Billion)
  54. Lupin Ltd: Revenue Share, By Segment, 2023 (%)
  55. Lupin Ltd: Revenue Share, By Region, 2023 (%)
  56. Pfizer Inc.: Net Sales, 2023-2033($ Billion)
  57. Pfizer Inc.: Revenue Share, By Segment, 2023 (%)
  58. Pfizer Inc.: Revenue Share, By Region, 2023 (%)
  59. Ypsomed AG.: Net Sales, 2023-2033($ Billion)
  60. Ypsomed AG.: Revenue Share, By Segment, 2023 (%)
  61. Ypsomed AG.: Revenue Share, By Region, 2023 (%)
  62. Wockhardt: Net Sales, 2023-2033($ Billion)
  63. Wockhardt: Revenue Share, By Segment, 2023 (%)
  64. Wockhardt: Revenue Share, By Region, 2023 (%)
  65. Elli Lilly: Net Sales, 2023-2033($ Billion)
  66. Elli Lilly: Revenue Share, By Segment, 2023 (%)
  67. Elli Lilly: Revenue Share, By Region, 2023 (%)
  68. Biogenomics Ltd.: Net Sales, 2023-2033($ Billion)
  69. Biogenomics Ltd.: Revenue Share, By Segment, 2023 (%)
  70. Biogenomics Ltd.: Revenue Share, By Region, 2023 (%)
  71. Polas Biopharm: Net Sales, 2023-2033($ Billion)
  72. Polas Biopharm: Revenue Share, By Segment, 2023 (%)
  73. Polas Biopharm: Revenue Share, By Region, 2023 (%)
  74. Others: Net Sales, 2023-2033($ Billion)
  75. Others: Revenue Share, By Segment, 2023 (%)
  76. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:230
Countries covered:17
Companies covered::20
Forecast CAGR:6.12%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies